Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027614
Filing Date
2021-05-13
Accepted
2021-05-13 16:45:57
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-10q_20210331.htm 10-Q 2172769
2 EX-31.1 rptx-ex311_11.htm EX-31.1 20055
3 EX-31.2 rptx-ex312_7.htm EX-31.2 20056
4 EX-32.1 rptx-ex321_8.htm EX-32.1 8664
5 EX-32.2 rptx-ex322_6.htm EX-32.2 8668
  Complete submission text file 0001564590-21-027614.txt   5770667

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rptx-20210331.xml EX-101.INS 1068964
7 XBRL TAXONOMY EXTENSION SCHEMA rptx-20210331.xsd EX-101.SCH 39000
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptx-20210331_cal.xml EX-101.CAL 40212
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptx-20210331_def.xml EX-101.DEF 89480
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20210331_lab.xml EX-101.LAB 302145
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20210331_pre.xml EX-101.PRE 221053
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 21920351
SIC: 2834 Pharmaceutical Preparations